Hormone refractory disease
Author:
Publisher
Wiley
Subject
Oncology,Surgery
Reference40 articles.
1. , , : Orchidectomy and estrogens as secondary forms of treatment for metastatic prostatic cancer. In (eds): “Therapeutic Principles in Metastatic Pro-static Cancer.” New York: Alan R Liss, 1985, 335–349.
2. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
3. : Chemotherapy for advanced prostatic cancer. In (ed): “The Medical Management of Prostate Cancer II.” Berlin, Heidelberg: Springer-Verlag, 1991, 75–88.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Palliative radikale (Zysto-)Prostatektomie bei lokal fortgeschrittenem kastrationsresistenten Prostatakarzinom;Der Urologe;2011-07-30
2. New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK;Clinical Cancer Research;2010-04-27
3. Prostatakarzinom;Uroonkologie;2009
4. Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: Modelization using a standardized set of response criteria;The Prostate;2007
5. Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment;Journal of Cellular Biochemistry;2006
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3